Impact of a direct-to-consumer information campaign on prescription patterns for overactive bladder.

Masayoshi ZaitsuByung-Kwang YooJun TomioFumiaki NakamuraSatoshi ToyokawaYasuki Kobayashi

Published in: BMC health services research (2018)

The examined DTCI campaign appeared to increase the prescription rate among patients with overactive bladder for 15 weeks with a 15-week delay. Clinical outcomes of the patients with targeted diseases need to be monitored after DTCI campaigns by a future study.

Keyphrases

health information
cancer therapy
current status
healthcare
clinical trial
gestational age
social media
preterm birth
double blind